Chemical Structure : G1T38
CAS No.: 1628256-23-4
Catalog No.: PC-60397Not For Human Use, Lab Use Only.
G1T38 (Lerociclib, G1T 38) is a novel, potent and selective inhibitor of CDK4/6 with biochemical IC50 of 1 nM and 2 nM for CDK4/cyclin D1 and CDK6/cyclin D3, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $118 | In stock | |
10 mg | $188 | In stock | |
25 mg | $298 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
G1T38 (Lerociclib, G1T 38) is a novel, potent and selective inhibitor of CDK4/6 with biochemical IC50 of 1 nM and 2 nM for CDK4/cyclin D1 and CDK6/cyclin D3, respectively.
G1T38 (Lerociclib) shows weak inhibitory effect on CDK9/cyclin T (IC50=28 nM) and CDK5/p35 (IC50=832 nM), >1,000-fold selectivity over CDK1/2/7.
G1T38 (Lerociclib) decreases RB1 phosphorylation, causes G1 arrest, and inhibits cell proliferation in a variety of CDK4/6-dependent tumorigenic cell lines.
G1T38 (Lerociclib, demonstrates equivalent or improved tumor efficacy compared to palbociclib in an ER+ breast cancer xenograft model.
M.Wt | 474.613 | |
Formula | C26H34N8O | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2'-((5-(4-isopropylpiperazin-1-yl)pyridin-2-yl)amino)-7',8'-dihydro-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidin]-6'-one |
1. Bisi JE, et al. Oncotarget. 2017 Jun 27;8(26):42343-42358.
2. Stice JP, et al. Mol Cancer Res. 2017 Jun;15(6):660-669.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright